lyso-pc has been researched along with Diabetes Mellitus, Type 1 in 1 studies
*Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderson, NL; Baynes, JW; Januszewski, AS; Jenkins, AJ; Thorpe, SR | 1 |
1 other study(ies) available for lyso-pc and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Chemical modification of proteins during peroxidation of phospholipids.
Topics: Adult; Blood Proteins; Catalysis; Copper Sulfate; Diabetes Mellitus, Type 1; Dicarboxylic Acids; Female; Glutarates; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Lipoproteins, LDL; Lysine; Lysophosphatidylcholines; Male; Oxidation-Reduction; Phospholipids; Ribonuclease, Pancreatic | 2005 |